Hugel Inc (145020)

Currency in KRW
253,500
-10,000(-3.80%)
Closed·
145020 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
252,500261,500
52 wk Range
208,500392,000
Key Statistics
Bid/Ask
253,000.00 / 253,500.00
Prev. Close
263,500
Open
258,500
Day's Range
252,500-261,500
52 wk Range
208,500-392,000
Volume
86.25K
Average Volume (3m)
84.56K
1-Year Change
-11.9792%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
145020 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
361,267
Upside
+42.51%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Hugel Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Hugel Company Profile

Hugel, Inc. develops and manufactures biopharmaceuticals in South Korea and internationally. The company offers Botulinum Toxin, a white injectable dry powder in a transparent glass vial for use in the treatment of positive essential eyelid convulsion in adults over 18 years of age; improvement of severe lasso wrinkles associated with corrugator muscles and/or procerus muscle activities in adults aged between 18 and 65; treatment of upper limb stroke; and treatment of dynamic equinus foot deformity in children with cerebral palsy over 2 years of age, as well as improvement of external angles of secondary ideals related to orbicularis oculi muscle activity in adults aged between 19 and 65 under the Botulax, Regenox, Zentox, Reage, Magnion, Hugel Toxin, Juvenlife, Botulim, and Botoshot brands. It also provides hyaluronic acid filler under the Dermalax, and The Chaeum brand names; cosmetics under the Wellage brand; and medical devices under BlueRose brand name. Hugel, Inc. was founded in 2001 and is headquartered in Chuncheon-si, South Korea.

Employees
594

Compare 145020 to Peers and Sector

Metrics to compare
145020
Peers
Sector
Relationship
P/E Ratio
19.8x−5.5x−0.5x
PEG Ratio
3.02−0.100.00
Price/Book
3.0x2.7x2.6x
Price / LTM Sales
6.4x11.0x3.3x
Upside (Analyst Target)
38.1%11.6%47.1%
Fair Value Upside
Unlock12.2%5.8%Unlock

Analyst Ratings

14 Buy
1 Hold
0 Sell
Ratings:
15 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 361,267
(+42.51% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Macquarie
Buy340,000.00+34.12%320,000.00Maintain14/01/2026
Morgan Stanley
Hold324,000.00+27.81%375,000.00Maintain02/01/2026
Macquarie
Buy320,000.00+26.23%440,000.00Maintain06/11/2025
Citi
Buy400,000.00+57.79%450,000.00Maintain16/10/2025
CLSA
Buy420,000.00+65.68%450,000.00Upgrade13/10/2025

Earnings

Latest Release
Feb 11, 2026
EPS / Forecast
3,516.22 / 4,497.54
Revenue / Forecast
119.10B / 112.59B
EPS Revisions
Last 90 days

Hugel (145020) Income Statement & Profits

People Also Watch

382,000
196170
-2.05%
184,400
298380
-2.54%
58,200
204320
-4.12%
601,000
128940
-2.12%
2,384,000
298040
-0.87%

FAQ

What Is the Hugel (145020) Share Price Today?

The live Hugel share price today is 253,500

What Stock Exchange Does Hugel (145020) Trade On?

Hugel is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Hugel?

The stock symbol (also called a 'ticker') for Hugel is "145020."

What Is the Current Hugel Market Cap?

As of today, Hugel market capitalisation is 2.74T.

What Is Hugel's (145020) Earnings Per Share (TTM)?

The Hugel EPS is currently 12,776.25 (Trailing Twelve Months).

When Is the Next Hugel Earnings Date?

Hugel's next earnings report will be released on 07/05/2026.

Is 145020 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Hugel moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Hugel Stock Split?

Hugel has split 1 times. (See the 145020 stock split history page for full effective split date and price information.)

How Many Employees Does Hugel Have?

Hugel has 594 employees.

What is the current trading status of Hugel (145020)?

As of 15 Feb 2026, Hugel (145020) is trading at a price of 253,500, with a previous close of 263,500. The stock has fluctuated within a day range of 252,500 to 261,500, while its 52-week range spans from 208,500 to 392,000.

What Is Hugel (145020) Price Target According to Analysts?

The average 12-month price target for Hugel is KRW361,267, with a high estimate of KRW450000 and a low estimate of KRW279000. 14 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +42.51% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.